Abstract
Gene delivery by electroporation is an efficient method for transfecting genes into various tissues including tumors. Here we present the treatment protocol used in a phase 1 study on gene electrotransfer of plasmid DNA encoding an antiangiogenic peptide into cutaneous melanoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gothelf A, Gehl J (2010) Gene electrotransfer to skin; review of existing literature and clinical perspectives. Curr Gene Ther 10(4):287–299
Heller LC, Heller R (2006) In vivo electroporation for gene therapy. Hum Gene Ther 17(9):890–897
Mir LM, Moller PH, Andre F et al (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54:83–114
Heller LC, Heller R (2011) Gene electrotransfer to tumor. In: Kee ST, Gehl J, Lee EW (eds) Clinical aspects of electroporation, 1st edn. Springer, New York, pp 159–164
Daud AI, DeConti RC, Andrews S et al (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26(36):5896–5903
Cheresh DA, Stupack DG (2008) Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27(48):6285–6298
Avraamides CJ, Garmy-Susini B, Varner JA (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8(8):604–617
Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264(5158):569–571
Johnson JP (1999) Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18(3):345–357
Kuphal S, Bauer R, Bosserhoff AK (2005) Integrin signaling in malignant melanoma. Cancer Metastasis Rev 24(2):195–222
Trochon-Joseph V, Martel-Renoir D, Mir LM et al (2004) Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res 64(6):2062–2069
Spanggaard I, Snoj M, Cavalcanti A et al (2013) Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev 24(3):99–107
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Spanggaard, I., Gehl, J. (2015). Antiangiogenic Metargidin Peptide (AMEP) Gene Therapy in Disseminated Melanoma. In: Walther, W., Stein, U. (eds) Gene Therapy of Solid Cancers. Methods in Molecular Biology, vol 1317. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2727-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2727-2_20
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2726-5
Online ISBN: 978-1-4939-2727-2
eBook Packages: Springer Protocols